Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Trumps victory in Iowa raises key questions for Republicans

Published

4 months ago

on

Ron DeSantis edges out Nikki Haley for second place in first GOP presidential nominating contest.

Former President Donald Trump cruised to a landslide victory in the Iowa caucuses.

The contest marked the first for the 2024 Republican presidential nominating calendar.

Now, the focus is shifting to New Hampshire and beyond.

Keith Nahigian, the President of Nahigian Strategies joins Veronica Dudo to discuss.

Related Topics:

Veronica Dudo is the U.S. Correspondent for Ticker News covering America’s biggest headlines. As an Emmy® Award nominated global journalist, Veronica has traveled across the country and around the world reporting on historical events that connect all citizens. Lauded as an award-winning international journalist, Veronica has executed stellar news coverage for NBC News, CBS News, The Hill, ME-TV Network and AOL. Her stories have highlighted a plethora of topics ranging from breaking news and politics to economic affairs across the USA, European Union, and Asia; cultural affairs; globalization; governance; education; and sustainability.

Continue Reading

News

Does American media have TikTok bias?

Published

51 mins ago

on

May 16, 2024

By

While the fate of TikTok remains uncertain in the U.S.—there is no shortage of possibilities.

Euro Bloch is a comprehensive program designed to highlight the breadth of topics and issues within the EU political landscape. It offers insightful analysis within the evolving framework of relations between the European Union and Australia/Asia-Pacific region. Hosted by Natanael Bloch.

Next month’s EU elections are looming, with the far-right gaining traction. In this episode, Natanael is joined by Professor Bruce Wilson, Director of EU Centre of Excellence at RMIT University. #EURO BLOCH

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

1 day ago

on

May 15, 2024

By

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

Trending Now